Parental perspective on the risk of infertility and fertility preservation options for children and adolescents with sickle cell disease considering hematopoietic stem cell transplantation
Pediatric Blood & Cancer · 2023
DOI: 10.1002/pbc.30276 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2023. Verfasst von Cynthia B Sinha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology-Oncology-BMT, Emory University, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Fertility Preservation, Hematopoietic Stem Cell Transplantation, Graft vs Host Disease, Anemia, Sickle Cell. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Institutes of Health.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Allogeneic hematopoietic stem cell transplantation (HCT) performed in children from human leukocyte antigen (HLA)‐identical related donors is associated with very high survival rates and disease‐free survival. Patients are exposed to gonadotoxic alkylating agents or irradiation in the HCT conditioning regimen. Consequently, infertility is a major long‐term complication of HCT for sickle cell disease (SCD). We sought to understand how caregivers perceive the risk of infertility from HCT, how they perceive the options for fertility preservation, and how this risk perception impacted their decision‐making to pursue HCT. Procedures We conducted qualitative interviews with primary caregivers after a consultation for HCT for SCD. Data were analyzed using descriptive qualitative analysis.
Results
We interviewed 19 primary caregivers who had attended a consultation with an HCT physician (female, age 25–59 [median 39] years). Eleven participants reported that their child had an available HLA‐matched donor. Analysis revealed that (i) mothers were worried about death and graft‐versus‐host disease from HCT, more than about the risk of infertility; (ii) parents have a realistic understanding of the risk of infertility after HCT and take it into consideration in decision‐making; (iii) parents report multiple barriers to fertility preservation.
Conclusion
For parents actively considering HCT for their child with SCD, the risk of infertility while important was not a barrier to pursuing HCT. Inconvenience and invasiveness of fertility preservation procedures are some of the barriers to pursuing fertility preservation for their child. Future research must aim at addressing these barriers to fertility preservation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Hematology-Oncology-BMT, Emory University, Atlanta, Georgia, USA.
- Aflac Cancer and Blood Disorders, Children's healthcare of Atlanta, Atlanta, Georgia, USA.
- Yale Pediatric Hematology & Oncology, Yale School of Medicine, New Haven, Connecticut, USA.
ORCID-Profile: Nitya Bakshi, Lakshmanan Krishnamurti
Förderung
- NHLBI NIH HHS
- National Institutes of Health
Zitieren
APA
Sinha, C. B., Meacham, L. R., Bakshi, N., Ross, D., & Krishnamurti, L. (2023). Parental perspective on the risk of infertility and fertility preservation options for children and adolescents with sickle cell disease considering hematopoietic stem cell transplantation. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30276
Vancouver
Sinha CB, Meacham LR, Bakshi N, Ross D, Krishnamurti L. Parental perspective on the risk of infertility and fertility preservation options for children and adolescents with sickle cell disease considering hematopoietic stem cell transplantation. Pediatric Blood & Cancer. 2023. doi:10.1002/pbc.30276
BibTeX
@article{Sinha2023,
author = {Sinha, Cynthia B and Meacham, Lillian R and Bakshi, Nitya and Ross, Diana and Krishnamurti, Lakshmanan},
title = {Parental perspective on the risk of infertility and fertility preservation options for children and adolescents with sickle cell disease considering hematopoietic stem cell transplantation},
journal = {Pediatric Blood & Cancer},
year = {2023},
doi = {10.1002/pbc.30276}
}
EUVIMED